BridgeMD
New treatment option for Fibromyalgia Syndrome
Official title Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome
ClinicalTrials.gov ID: NCT06539793
What this study is testing
- What it's testing
- Fibromyalgia is the third most common musculoskeletal condition in terms of prevalence, after lumbar pain and osteoarthritis. Its prevalence is around 2-4 % and is more frequent in women than in men; the prevalence is highest in age the range of 40-60 years.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 35
You may be able to join if
- Patients fibromyalgia from both genders.
- The duration of fibromyalgia is more than 6 month (all patients with history of cervical or lumbar pain) and following diagnosis of FM using the 2016...
- Their ages will be ranged from 25-35 years old.
- They will be medically stable and have sufficient cognitive abilities that enable them to understand and follow instruction according to Montreal...
You likely can't join if
- Other Neurological diseases as stroke , multiple sclerosis, Parkinson's disease and motor neuron disease
- Pacemaker
- Spinal fusion-cervical or lumbar
- Metal implants in the spine
- Pregnancy
- Epilepsy
See the full eligibility criteria
- Patients fibromyalgia from both genders.
- The duration of fibromyalgia is more than 6 month (all patients with history of cervical or lumbar pain) and following diagnosis of FM using the 2016 revised FM criteria, on the basis of the ACR-2010 criteria.
- Their ages will be ranged from 25-35 years old.
- They will be medically stable and have sufficient cognitive abilities that enable them to understand and follow instruction according to Montreal Cognitive Assessment (MoCA) \>26.
- Other Neurological diseases as stroke , multiple sclerosis, Parkinson's disease and motor neuron disease
- Pacemaker
- Spinal fusion-cervical or lumbar
- Metal implants in the spine
- Pregnancy
- Epilepsy
- Severe psychiatric disorder or alcohol and drug abuse.
- Unstable medical condition which could compromise the participant's welfare or confound the study results.
- Uncontrolled blood pressure or diabetes
- Visual or auditory problems.
- Active inflammatory conditions
The study team makes the final eligibility decision.
Where it's taking place
- Sadat, Menoufia, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sadat, Menoufia, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.